HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Stefan Faderl Selected Research

Cytarabine (Cytosar-U)

1/2021Quality-adjusted Time Without Symptoms of disease or Toxicity (Q-TWiST) analysis of CPX-351 versus 7 + 3 in older adults with newly diagnosed high-risk/secondary AML.
1/2021Older adults with newly diagnosed high-risk/secondary AML who achieved remission with CPX-351: phase 3 post hoc analyses.
2/2017Phase 2 study of low-dose clofarabine plus cytarabine for patients with higher-risk myelodysplastic syndrome who have relapsed or are refractory to hypomethylating agents.
7/2015Final results of a phase 2 trial of clofarabine and low-dose cytarabine alternating with decitabine in older patients with newly diagnosed acute myeloid leukemia.
5/2015Incidence of and risk factors for involvement of the central nervous system in acute myeloid leukemia.
10/2014Gemtuzumab ozogamicin with fludarabine, cytarabine, and granulocyte colony stimulating factor (FLAG-GO) as front-line regimen in patients with core binding factor acute myelogenous leukemia.
11/2013Clofarabine, idarubicin, and cytarabine (CIA) as frontline therapy for patients ≤60 years with newly diagnosed acute myeloid leukemia.
10/2012A randomized controlled trial of an intensive insulin regimen in patients with hyperglycemic acute lymphoblastic leukemia.
9/2012Clofarabine plus low-dose cytarabine followed by clofarabine plus low-dose cytarabine alternating with decitabine in acute myeloid leukemia frontline therapy for older patients.
8/2012Twice-daily fludarabine and cytarabine combination with or without gentuzumab ozogamicin is effective in patients with relapsed/refractory acute myeloid leukemia, high-risk myelodysplastic syndrome, and blast- phase chronic myeloid leukemia.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Stefan Faderl Research Topics

Disease

86Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2021 - 08/2002
60BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
05/2015 - 03/2002
52Myelodysplastic Syndromes (Myelodysplastic Syndrome)
04/2019 - 08/2002
43Leukemia
01/2016 - 03/2002
36Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2018 - 03/2002
34B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
03/2017 - 08/2002
31Philadelphia Chromosome
12/2015 - 04/2002
25Neoplasms (Cancer)
10/2014 - 03/2003
12Thrombocytopenia (Thrombopenia)
01/2015 - 09/2002
10Infections
11/2015 - 03/2003
10Neutropenia
04/2014 - 06/2003
10Hematologic Neoplasms (Hematological Malignancy)
11/2013 - 12/2003
9Residual Neoplasm
10/2011 - 01/2003
8Acute Promyelocytic Leukemia
01/2017 - 09/2004
8Pathologic Complete Response
12/2015 - 12/2003
8Diarrhea
06/2014 - 08/2002
8Anemia
07/2013 - 04/2002
6Blast Crisis (Blast Phase)
03/2014 - 05/2002
5Disease Progression
10/2013 - 07/2004
5Chromosome Aberrations (Chromosome Abnormalities)
06/2011 - 08/2002
4Exanthema (Rash)
11/2015 - 03/2003
4Nausea
07/2015 - 05/2004
4Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic)
04/2014 - 06/2003
4Pneumonia (Pneumonitis)
11/2012 - 02/2004
4Hairy Cell Leukemia
10/2011 - 12/2003
4Multiple Myeloma
08/2011 - 11/2003
4Hyperbilirubinemia
01/2011 - 03/2003
4Mucositis
10/2008 - 08/2002
4Lymphoproliferative Disorders (Lymphoproliferative Disorder)
12/2007 - 04/2002
3Leukocytosis (Pleocytosis)
01/2017 - 12/2003
3Central Nervous System Diseases (CNS Diseases)
05/2015 - 09/2004
3Fever (Fevers)
08/2013 - 02/2004
3Myeloid Leukemia (Leukemia, Myelocytic)
02/2013 - 03/2003
3Febrile Neutropenia
11/2012 - 02/2010
3Splenomegaly
10/2011 - 10/2004
3Cytopenia
09/2011 - 05/2006
3Invasive Fungal Infections
01/2011 - 02/2004
3Fatigue
02/2010 - 06/2003
3Lymphoma (Lymphomas)
11/2009 - 06/2005
3Myeloproliferative Disorders (Myeloproliferative Disorder)
06/2008 - 06/2003

Drug/Important Bio-Agent (IBA)

47Imatinib Mesylate (Gleevec)FDA Link
02/2014 - 05/2002
44Cytarabine (Cytosar-U)FDA LinkGeneric
01/2021 - 03/2002
23Clofarabine (Clolar)FDA Link
02/2017 - 03/2003
21fludarabineIBA
03/2017 - 04/2002
18Cyclophosphamide (Cytoxan)FDA LinkGeneric
03/2017 - 03/2002
18Rituximab (Mabthera)FDA Link
03/2017 - 04/2003
14Vincristine (Oncovin)FDA LinkGeneric
12/2015 - 03/2002
14Alemtuzumab (Campath)FDA Link
06/2013 - 05/2003
13Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric
01/2017 - 08/2002
12DecitabineFDA Link
04/2019 - 08/2003
11Dexamethasone (Maxidex)FDA LinkGeneric
10/2012 - 03/2002
10Pharmaceutical PreparationsIBA
01/2021 - 03/2004
10Monoclonal AntibodiesIBA
01/2018 - 12/2003
10Dasatinib (BMS 354825)FDA Link
12/2015 - 06/2008
10NucleosidesIBA
06/2014 - 12/2003
10Interferon-alpha (Interferon Alfa)IBA
06/2012 - 04/2002
8Tyrosine Kinase InhibitorsIBA
11/2015 - 09/2003
7Arsenic Trioxide (Trisenox)FDA Link
01/2017 - 09/2004
7Tretinoin (Retinoic Acid)FDA LinkGeneric
01/2017 - 09/2004
7Gemtuzumab (Mylotarg)FDA Link
01/2017 - 01/2003
7Biological ProductsIBA
09/2013 - 08/2002
7Doxorubicin (Adriamycin)FDA LinkGeneric
10/2012 - 03/2002
6Lenalidomide (CC 5013)FDA Link
01/2016 - 06/2008
6Hemoglobins (Hemoglobin)IBA
10/2014 - 04/2002
6InterferonsIBA
06/2012 - 06/2003
6Proteins (Proteins, Gene)FDA Link
12/2011 - 03/2002
6Alkylating AgentsIBA
07/2009 - 05/2004
5Daunorubicin (Cerubidine)FDA LinkGeneric
01/2021 - 03/2003
5Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
09/2014 - 04/2002
5Azacitidine (5 Azacytidine)FDA Link
06/2013 - 10/2007
5CytokinesIBA
05/2009 - 08/2002
4Transaminases (Aminotransferases)IBA
12/2015 - 10/2008
4Phosphotransferases (Kinase)IBA
02/2015 - 06/2003
4Core Binding Factors (Core-Binding Factor)IBA
10/2014 - 12/2008
4Granulocyte Colony-Stimulating Factor (G-CSF)IBA
10/2014 - 09/2006
4Sorafenib (BAY 43-9006)FDA Link
06/2013 - 04/2010
4Methotrexate (Mexate)FDA LinkGeneric
10/2012 - 03/2002
4Cyclosporine (Ciclosporin)FDA LinkGeneric
05/2012 - 03/2003
4Bortezomib (Velcade)FDA Link
08/2011 - 10/2003
4AnthracyclinesIBA
01/2011 - 08/2002
4laromustine (VNP40101M)IBA
01/2007 - 05/2004
4troxacitabineIBA
01/2007 - 03/2003
3ProdrugsIBA
01/2016 - 05/2009
3Prednisone (Sone)FDA LinkGeneric
12/2015 - 09/2010
3EnzymesIBA
07/2015 - 12/2005
3Histone Deacetylase InhibitorsIBA
06/2012 - 11/2006
3Proteasome InhibitorsIBA
08/2011 - 10/2003
3DNA (Deoxyribonucleic Acid)IBA
04/2011 - 12/2003
3Itraconazole (Sporanox)FDA LinkGeneric
01/2011 - 02/2004
3Pentostatin (Nipent)FDA LinkGeneric
11/2009 - 01/2006
3ErythropoietinFDA Link
09/2009 - 04/2002
3TransferasesIBA
11/2007 - 04/2005

Therapy/Procedure

99Therapeutics
01/2021 - 03/2002
30Drug Therapy (Chemotherapy)
01/2021 - 03/2002
13Salvage Therapy
10/2013 - 04/2003
9Induction Chemotherapy
08/2012 - 02/2004
7Stem Cell Transplantation
05/2015 - 09/2002
4Drug Tapering
07/2010 - 06/2003
3Radiotherapy
10/2014 - 09/2004
3Intravenous Infusions
05/2010 - 12/2003